Recon: FDA approves Pfizer’s RSV vaccine for older adults; Roche eyes sale of California biologics facility
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy